• Connect
  • Bookmark Us
  • AF Twitter
  • AF YouTube
  • AF LinkedIn
  • Subscribe
  • Subscription Link
Arent Fox
  • Firm

    • History

    • Awards & Recognitions

    • Diversity

      • Overview
      • Diversity Scholarship
      • Employees on Diversity
      • LGBT Initiative
      • Women’s Leadership Development Initiative
    • Alumni

    • Pro Bono

      • Overview
      • Current Pro Bono Work
      • Community Involvement
      • Pro Bono Newsletter
      • Pro Bono Awards & Honors
      • FAQ: Pro Bono & Working at Arent Fox
    • Leadership

      • Firm Management
      • Administrative Leadership
  • Deals & Cases

  • People

  • Practices & Industries

    • Practices

      • Advertising, Promotions & Data Security
      • Government Relations
      • Antitrust & Competition Law
      • Health Care
      • Appellate
      • Insurance & Reinsurance
      • Bankruptcy & Financial Restructuring
      • Intellectual Property
      • Commercial Litigation
      • International Trade
      • Communications, Technology & Mobile
      • Labor & Employment
      • Construction
      • Municipal & Project Finance
      • Consumer Product Safety
      • OSHA
      • Corporate & Securities
      • Political Law
      • ERISA
      • Real Estate
      • Environmental
      • Tax
      • FDA Practice (Food & Drug)
      • Wealth Planning & Management
      • Finance
      • White Collar & Investigations
      • Government Contractor Services
    • Industries

      • Automotive
      • Energy Law & Policy
      • Fashion, Luxury Goods & Retail
      • Government Real Estate & Public Buildings
      • Hospitality
      • Life Sciences
      • Long Term Care & Senior Living
      • Media & Entertainment
      • Medical Devices
      • Nonprofit
      • Sports
  • Newsroom

    • Alerts

    • Events

    • Media Mentions

    • Press Releases

    • Social Media

    • Subscribe

  • Careers

    • Lawyers

    • Law Students

    • Professional Staff

  • Contact

    • Washington, DC

    • New York, NY

    • Los Angeles, CA

    Alerts

    • Newsroom Overview
      • Alerts

        Alerts by Criteria

        E.g., 1 / 22 / 2013
        E.g., 1 / 22 / 2013
      • Events
      • Media Mentions
      • Press Releases
      • Social Media
      • Subscribe

    You are here

    Home » Newsroom » Alerts

    Share

    • Printer-friendly version
    • Send by email
    • A Title
    • A Title
    • A Title
    • A
    • A
    • A

    Egyptian Goddess v Swisa: Reexamining the Point of Novelty Test for Design Patent Infringement

    June 4, 2008

    On June 2, 2008 the US Court of Appeals for the Federal Circuit (CAFC) heard oral arguments in the much anticipated design patent case, Egyptian Goddess, Inc. (EGI) v. Swisa Inc.  Arguments were presented before the entire panel of thirteen CAFC judges (en banc), a first ever for the CAFC in rehearing a design patent case. The CAFC had agreed to review one of the more complex issues surrounding design patent infringement, the point of novelty test.

    The case centered on Swisa’s alleged infringement of EGI’s design patent for a nail buffer.  EGI’s nail buffer claimed four sides, three of which were padded. Swisa, on the other hand, created and sold a nail buffer having four sides, all four of which were padded.

    Prior case law had established that two tests needed to be met to establish design patent infringement. The first test, the “ordinary observer test,” was established in the landmark Supreme Court design patent case Gorham Co. v. White, 81 U.S. 511 (1871). The test is whether in the eyes of an ordinary observer an accused design appears substantially similar to the patented design. The second test, the “point of novelty test,” requires that the accused design also incorporates the novel aspects of the substantially similar patented design.

    A lower court had ruled that Swisa’s nail buffer did not contain the point of novelty of the EGI patented design and therefore, did not infringe the EGI design patent. On appeal, the question before the court was whether the point of novelty test was an adequate method for establishing infringement. If not, how should it be changed?

    During oral arguments, the judges focused on whether there was any reason for overturning a test that had been established by previous case law. Chief Judge Paul R. Michel asked why the law should be changed in the absence of a Supreme Court decision, congressional legislation, or evidence that the application of the point of novelty test was not working. Without such evidence, Chief Judge Michel verbalized the court’s reluctance to disregard the point of novelty test completely.

    As an alternative, the court considered the question of whether the point of novelty test should remain part of the patent holder’s burden on infringement or should the burden be placed on the defendant as an available defense. However, the court questioned whether this option would really remedy the concern of gamesmanship seen when each party selects self-serving prior art references for determining points of novelty.

    The judges also directed discussion toward the merits of using a “three way test”. Under this test, infringement would be decided by comparing the infringing design to both prior art and the patented design. The “three way test,” however, raises similar issues, including which prior art to use in making the comparison.

    The court’s final opinion in Egyptian Goddess, Inc. v. Swisa, Inc. may represent another landmark decision in the history of design patents. The Court of Appeals for the Federal Circuit may not completely walk away from the “point of novelty” test, but some change is probably in store for the future of infringement in the design patent world.

    Related People

    • George E. Oram

    Related Practices

    Intellectual Property
    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Contact

    Footer Main

    • Firm
    • Deals & Cases
    • People
    • Practices & Industries
    • Newsroom
    • Careers
    • Subscribe
    • Alumni
    • Diversity
    • Legal Notice
    • Privacy Policy
    • Social Media Disclaimer
    • Nondiscrimination
    • Site Map
    • Client/Staff Login

    Offices

    • Washington, DC
      1717 K Street, NW
      Washington, DC 20036
      Tel: 202.857.6000
    • New York, NY
      1675 Broadway
      New York, New York 10019
      Tel: 212.484.3900
    • Los Angeles, CA
      555 West Fifth Street, 48th Floor
      Los Angeles, California 90013
      Tel: 213.629.7400
    • © Copyright 2013 Arent Fox LLP. All Rights Reserved.

      Legal Disclaimer
      Contents may contain attorney advertising under the laws of some states. Prior results do not guarantee a similar outcome.